Invention Grant
- Patent Title: Oral suspension comprising telmisartan
-
Application No.: US16394610Application Date: 2019-04-25
-
Publication No.: US10537523B2Publication Date: 2020-01-21
- Inventor: Detlef Mohr , Stefan Lehner
- Applicant: Boehringer Ingelheim Vetmedica GmbH
- Agent Judy Jarecki-Black
- Priority: EP09160771 20090520
- Main IPC: A61K31/4184
- IPC: A61K31/4184 ; A61K9/08 ; A61K47/26 ; A61P9/12 ; A61K9/00 ; A61K47/10
Abstract:
A drinkable pharmaceutical solution includes telmisartan or a pharmaceutically acceptable salt, hydrate or polymorph thereof, where the telmisartan has a concentration of 1 to 10 mg/ml within the drinkable pharmaceutical solution, and the drinkable pharmaceutical solution has a pH of 10.
Public/Granted literature
- US20190247305A1 ORAL SUSPENSION COMPRISING TELMISARTAN Public/Granted day:2019-08-15
Information query
IPC分类:
